Clinical trials
Phase 3 Dermatitis, Atopic trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Active, not recruiting | 4 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 6 |
| Eli Lilly and Company | 6 |
| Pfizer | 5 |
| AbbVie | 4 |
| LEO Pharma | 3 |
| Regeneron Pharmaceuticals | 3 |
| Sanofi | 3 |
| Kang Stem Biotech Co., Ltd. | 2 |
| Amorepacific Corporation | 1 |
| Chungbuk National University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatitis, Atopic | 35 |
| Eczema | 12 |
| Dermatitis | 4 |
| Skin Diseases | 4 |
| Genetic Diseases, Inborn | 1 |
| Hypersensitivity | 1 |
| Hypersensitivity, Immediate | 1 |
| Immune System Diseases | 1 |
| Skin Diseases, Eczematous | 1 |
| Skin Diseases, Genetic | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.